Arc Ventures
VC Fund
New York, United States
Arc Ventures is a VC fund in New York focused on Health Care and Energy. New York based investing firm, founder friendly and partner to 50 VC funds
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Arc Ventures invests in
Stages Arc Ventures invests in
Countries Arc Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Irene Susmano
|
|||
Joseph Korff
|
|||
3 more contacts available
Investment Focus
Industry
- Health Care 2 (40%)
- Energy 1 (20%)
- FinTech 1 (20%)
- Medical 1 (20%)
- Biotechnology 1 (20%)
Stage
- Seed 2 (40%)
- Series A 2 (40%)
Country
- Israel 2 (40%)
- United States 2 (40%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Irene Susmano
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
|
Joseph Korff
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Niv-AI
|
Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware. | $12M / Seed / Mar 17, 2026 | |
MetaSight Diagnostics
|
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics). | $8M / Series A / Nov 13, 2024 | |
Averna Therapeutics
|
Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells. | $85M / Series A / Jun 25, 2024 | |
Nirvana Health
|
Nirvana Health is a mental health company that provides an insurance intelligence platform for therapists and their patients. It builds tools that allow care providers across specialties to check the coverage from intake to continuous management of the patient lifecycle saving hours and resources. It also utilizes AI and machine learning to provideclient billing, payment plans, reimbursement services, finance management, and other services. Its platform improves the patient experience by allowing patients to pay upfront at the time of the visit, which simplifies the appointment booking experience as a whole. For providers, this also substantially reduces claim denials for their finance and RCM teams. | $7.5M / Seed / Nov 16, 2021 | |
|
Nirvana Health
|
Nirvana Health is a mental health company that provides an insurance intelligence platform for therapists and their patients. It builds tools that allow care providers across specialties to check the coverage from intake to continuous management of the patient lifecycle saving hours and resources. It also utilizes AI and machine learning to provideclient billing, payment plans, reimbursement services, finance management, and other services. Its platform improves the patient experience by allowing patients to pay upfront at the time of the visit, which simplifies the appointment booking experience as a whole. For providers, this also substantially reduces claim denials for their finance and RCM teams. | $4.2M / Seed / Jun 10, 2021 |
Co-Investors
Everywhere Ventures
3 deals together
Alumni Ventures
2 deals together
Eniac Ventures
2 deals together
aMoon Fund
1 deal together
Aurora Capital Partners
1 deal together
Celtic House Asia Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Arc Ventures invest in?
Arc Ventures invests primarily in Health Care, Energy and FinTech startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Arc Ventures?
Public channels for Arc Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Arc Ventures?
The team at Arc Ventures includes Irene Susmano (Co-Founder) and Joseph Korff (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
